FI943100A0 - Ansamycin derivatives as anti-cogenic and anticancer agents - Google Patents

Ansamycin derivatives as anti-cogenic and anticancer agents

Info

Publication number
FI943100A0
FI943100A0 FI943100A FI943100A FI943100A0 FI 943100 A0 FI943100 A0 FI 943100A0 FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A0 FI943100 A0 FI 943100A0
Authority
FI
Finland
Prior art keywords
cogenic
anticancer agents
ansamycin derivatives
ansamycin
derivatives
Prior art date
Application number
FI943100A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI943100A (en
Inventor
Randall James Gallaschun
Mikel Paul Moyer
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943100A0 publication Critical patent/FI943100A0/en
Publication of FI943100A publication Critical patent/FI943100A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI943100A 1993-06-29 1994-06-28 Ansamycin derivatives as anthionogenic and anti-cancer agents FI943100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8506593A 1993-06-29 1993-06-29

Publications (2)

Publication Number Publication Date
FI943100A0 true FI943100A0 (en) 1994-06-28
FI943100A FI943100A (en) 1994-12-30

Family

ID=22189242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943100A FI943100A (en) 1993-06-29 1994-06-28 Ansamycin derivatives as anthionogenic and anti-cancer agents

Country Status (5)

Country Link
EP (1) EP0706516A1 (en)
JP (1) JP2794342B2 (en)
CA (1) CA2166320A1 (en)
FI (1) FI943100A (en)
WO (1) WO1995001342A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338000C (en) 1998-07-17 2009-12-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Water-soluble 4-thio-maleimido derivatives and methods for their production
EP1169319A4 (en) * 1999-04-09 2005-02-09 Sloan Kettering Institutefor C Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
AU2002217866A1 (en) * 2000-11-06 2002-05-15 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
ES2268068T3 (en) * 2001-03-30 2007-03-16 The Usa, Represented By The Secretary, Dept. Of Health And Human Services National Institutes Health DERIVED FROM GELDANAMYCIN USEFUL FOR THE TREATMENT OF CANCER.
EP1420747A4 (en) * 2001-08-06 2010-06-02 Kosan Biosciences Inc Benzoquinone ansamycins
JP2005504086A (en) 2001-09-24 2005-02-10 コンフォーマ セラピューティクス コーポレーション Process for producing 17-allylaminogeldanamycin (17-AAG) and other ansamycins
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
AU2003217393B8 (en) 2002-02-08 2009-06-25 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
EP1605931A4 (en) * 2003-03-13 2009-04-29 Conforma Therapeutics Corp Drug formulations having long and medium chain triglycerides
CA2545457A1 (en) 2003-11-12 2005-06-23 Kosan Biosciences, Inc. 11-o-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
AU2004309395C1 (en) 2003-12-23 2012-10-04 Infinity Discovery, Inc. Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
PE20081506A1 (en) 2006-12-12 2008-12-09 Infinity Discovery Inc ANSAMYCIN FORMULATIONS
JP5583680B2 (en) 2008-10-15 2014-09-03 インフィニティー ファーマスーティカルズ インコーポレイテッド Ansamycin hydroquinone composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US3987035A (en) * 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
BR9207024A (en) * 1992-01-06 1995-12-05 Pfizer Process and uses for 4,5-DI-hydrogeldanamycin and its hydroquinone

Also Published As

Publication number Publication date
JP2794342B2 (en) 1998-09-03
FI943100A (en) 1994-12-30
JPH08506356A (en) 1996-07-09
CA2166320A1 (en) 1995-01-12
EP0706516A1 (en) 1996-04-17
WO1995001342A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
FI973471A (en) Pyrazol-4-ylbenzoyl derivatives and their use as herbicides
FI935309A0 (en) Vattenloesliga manganpartiklar som medel Foer foerstaerkande av magnetisk resonanskontrast
FI943100A0 (en) Ansamycin derivatives as anti-cogenic and anticancer agents
NO20002162D0 (en) Tienopyrimidine and thienopyridine derivatives useful as anticancer agents
FI934373A0 (en) FABRIKATIONSPROCESS AV KOMPOSITTRAOD OCH KOMPOSITPRODUKTER SOM FAOTTS AVNAEMNDA TRAODEN
FI930489A (en) SULFOALKYLHYDROXIALKYLDERIVAT AV CELLULOSA OCH ANVAENDNING AV DEM I GIPS- OCH CEMENTHALTIGA MASSOR
DK0551048T3 (en) 2-Imidazone-5-one and 2-imidazoline-5-thione derivatives as fungicides
NO20000366D0 (en) O-substituted hydroxycoumaranone derivatives as anti-tumor and antimetastasis agents
FI935767A0 (en) Foerfarande och anordning Foer centrering av en stock oco Foer tillfoeringav en stock som skall centreras
FI964936A0 (en) Benzopyrans and their use as therapeutic agents
FI931701A (en) DERIVATIVES OF THE FACTOR WHICH ARE INHIBERATED, FRAMSTAELLNING OCH ANVAENDNING
FI961977A0 (en) N-substituted azabicycloalkane derivatives, their preparation and use
NO980009D0 (en) Triazoline and isocazoline bisoxime derivatives and their use as pesticides
DE69611758D1 (en) N-1-CARBOCYLALKYL DERIVATIVES FROM LSD
FI971462A0 (en) Benzioxazole derivatives and pesticide compositions containing the same
FI953106A0 (en) Difluoropentapeptide derivatives such as anti-inflammatory agents
EE9800054A (en) Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
FI922472A0 (en) GINGEROL- OCH GINGERDIOLDERIVAT SOM HYPOKOLESTEROLEMISKA OCH ANTIATEROSKLEROSTISKA MEDEL.
FI955335A0 (en) Bicyclopolyazamacrocyclophosphonium complex, complex and conjugate form
DK0660715T3 (en) Carbostyril derivatives as antiarrhythmic agents
FI931178A0 (en) FOERFARANDE OCH MEDEL FOER OEPPNANDE AV KUVERT
NO951299D0 (en) Polyamine derivatives as anti-cytomegaloviral agents
DK0920312T3 (en) Apoptosis-inducing adamantyl derivatives and their use as anticancer agents
FI933784A0 (en) FOERFARANDE OCH MEDEL FOER ATT UPPIVA VAETTENDRAG OCH ATT FOERBAETTRA FODRETS KVALITET
FI934005A0 (en) FOERFARANDE FOER VISNING AV PARKERINGSTID I EN BETALANORDNING FOER PARKERING OCH EN BETALANORDNING FOER PARKERING SOM VISAR PARKERINGSTID